Ethics approval and consent to participate
ATHOS-3 was sponsored by La Jolla Pharmaceutical Company and conducted under full oversight of site-level or central institutional review boards and ethics committees, per regional requirement. Written informed consent was obtained from all patients or their legal surrogates prior to inclusion.